Comparing development strategies for PD1/PDL1-based immunotherapies

Nat Rev Drug Discov. 2022 Jul;21(7):484. doi: 10.1038/d41573-022-00003-7.

Authors

Guanqiao Li, Yale Jiang, Yunhe Qin, Shuona Yuan, Xiaoyuan Chen

PMID: 34992259
DOI: 10.1038/d41573-022-00003-7

No abstract available

MeSH terms

B7-H1 Antigen*
Humans
Immunotherapy
Programmed Cell Death 1 Receptor*

Substances

B7-H1 Antigen
Programmed Cell Death 1 Receptor